Combinatorial therapy with three-dimensionally cultured adipose-derived stromal cells and self-assembling peptides to enhance angiogenesis and preserve cardiac function in infarcted hearts

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 10, 2017, Pages 2816-2827

  Kim, Ji Hyun ^a,b   Park, Yongdoo ^c,d   Jung, Youngmee ^a   Kim, Soo Hyun ^a   Kim, Sang Heon ^a,e  

^a Korea Institute of Science and Technology   (South Korea)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Korea University   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e University of Science and Technology (UST)   (South Korea)

Author keywords

adipose derived stromal cell; angiogenesis; cardiac tissue engineering; self assembling peptides; three dimensional cell mass; vascularization

Indexed keywords

BLOOD VESSELS; CARDIOLOGY; CELL CULTURE; CELL ENGINEERING; COPYRIGHTS; DISEASE CONTROL; PEPTIDES; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ADIPOSE-DERIVED STROMAL CELLS; ANGIOGENESIS; CARDIAC FUNCTIONS; CARDIAC TISSUE ENGINEERING; CELL MASS; MYOCARDIAL INFARCTION; SELF-ASSEMBLING PEPTIDES; THREE-DIMENSIONAL CELL MASS; TRANSPLANTED CELLS; VASCULARIZATION;

HEART;

FIBROBLAST GROWTH FACTOR; PEPTIDE DERIVATIVE; SELF ASSEMBLING DERIVATIVE; UNCLASSIFIED DRUG; PEPTIDE; VASCULOTROPIN A;

ADIPOSE TISSUE CELL; ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CELL SURFACE; CELL SURVIVAL; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENGRAFTMENT; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMOBILIZED CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPHEROID CELL; STROMA CELL; ADIPOSE TISSUE; APOPTOSIS; BLOOD VESSEL; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CELL PROTECTION; CYTOLOGY; DRUG EFFECT; HEART FUNCTION TEST; INJECTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION;

ADIPOSE TISSUE; ADULT; APOPTOSIS; BLOOD VESSELS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYTOPROTECTION; HEART FUNCTION TESTS; HUMANS; INJECTIONS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PHENOTYPE; STEM CELL TRANSPLANTATION; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84971671432     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2181     Document Type: Article

References (43)

1. Barbash IM, Chouraqui P, Baron J et al. 2003; Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863–868.
2. Bhang SH, Cho SW, La WG et al. 2011; Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32: 2734–2747.
3. Bhatia RS, Tu JV, Lee DS et al. 2006; Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355: 260–269.
4. Christman KL, Lee RJ. 2006; Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48: 907–913.
5. Davis ME, Hsieh PC, Grodzinsky AJ et al. 2005a; Custom design of the cardiac microenvironment with biomaterials. Circ Res 97: 8–15.
6. Davis ME, Motion JP, Narmoneva DA et al. 2005b; Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111: 442–450.
7. Ellis-Behnke RG, Liang YX, You SW et al. 2006; Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A 103: 5054–5059.
8. Freyman T, Polin G, Osman H et al. 2006; A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114–1122.
9. Genove E, Shen C, Zhang S et al. 2005; The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 26: 3341–3351.
10. Gnecchi M, Zhang Z, Ni A et al. 2008; Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204–1219.
11. Han M, Park IS, Kim SH et al. 2009; Design and characterization of a maltose binding protein-linked growth factor for matrix engineering. Biotechnol Lett 31: 1677–1684.
12. Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ et al. 2008; Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 187: 263–274.
13. Horii A, Wang X, Gelain F et al. 2007; Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3-D migration. PLoS One 2: e190.
14. Hsieh PC, MacGillivray C, Gannon J et al. 2006a; Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 114: 637–644.
15. Hsieh PCH, Davis ME, Gannon J et al. 2006b; Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116: 237–248.
16. Jawad H, Ali NN, Lyon AR et al. 2007; Myocardial tissue engineering: a review. J Tissue Eng Regen Med 1: 327–342.
17. Jessup M, Brozena S. 2003; Heart failure. N Engl J Med 348: 2007–2018.
18. Kang JM, Han M, Park IS et al. 2012; Adhesion and differentiation of adipose-derived stem cells on a substrate with immobilized fibroblast growth factor. Acta Biomater 8: 1759–1767.
19. Kim JH, Jung Y, Kim SH et al. 2011; The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials 32: 6080–6088.
20. Kim JH, Jung Y, Kim BS et al. 2013a; Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia model. Biomaterials 34: 1657–1668.
21. Kim JH, Park IS, Park Y et al. 2013b; Therapeutic angiogenesis of three-dimensionally cultured adipose-derived stem cells in rat infarcted hearts. Cytotherapy 15: 542–556.
22. Laflamme MA, Murry CE. 2005; Regenerating the heart. Nat Biotechnol 23: 845–856.
23. Lin YD, Yeh ML, Yang YJ et al. 2010; Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 122: S132–S141.
24. Metzger W, Sossong D, Bachle A et al. 2011; The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells. Cytotherapy 13: 1000–1012.
25. Nakagami H, Morishita R, Maeda K et al. 2006; Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 13: 77–81.
26. Narmoneva DA, Oni O, Sieminski AL et al. 2005; Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 26: 4837–4846.
27. Park IS, Han M, Rhie JW et al. 2009; The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism. Biomaterials 30: 6835–6843.
28. Park IS, Chung PS, Ahn JC. 2014a; Enhanced angiogenic effect of adipose-derived stromal cell spheroid with low-level light therapy in hind limb ischemia mice. Biomaterials 35: 9280–9289.
29. Park IS, Kang JA, Kang J et al. 2014b; Therapeutic effect of human adipose-derived stromal cells cluster in rat hind-limb ischemia, Anat Rec (Hoboken) 297: 2289–2298.
30. Park IS, Rhie JW, Kim SH. 2014c; A novel three-dimensional adipose-derived stem cell cluster for vascular regeneration in ischemic tissue. Cytotherapy 16: 508.
31. Roger VL, Go AS, Lloyd-Jones DM et al. 2011; Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 123: e18–e209.
32. Rubina K, Kalinina N, Efimenko A et al. 2009; Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 15: 2039–2050.
33. Sanz-Ruiz R, Gutierrez Ibanes E, Arranz AV et al. 2010; Phases I–III clinical trials using adult stem cells. Stem Cells Int 2010: 579142.
34. Segers VF, Lee RT. 2008; Stem-cell therapy for cardiac disease. Nature 451: 937–942.
35. Sutton MG, Sharpe N. 2000; Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981–2988.
36. Terrovitis JV, Smith RR, Marban E. 2010; Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106: 479–494.
37. Valcarcel M, Arteta B, Jaureguibeitia A et al. 2008; Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis. J Transl Med 6:
38. van Dijk A, Niessen HW, Ursem W et al. 2008; Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cells. Cell Tissue Res 332: 289–298.
39. Wang QD, Sjoquist PO. 2006; Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement. Pharmacol Res 53: 331–340.
40. Wei H, Ooi TH, Tan G et al. 2010; Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev 15: 1–14.
41. Yeghiazarians Y, Gaur M, Zhang Y et al. 2012; Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition, Cytotherapy 14: 223–231.
42. Yoon SJ, Fang YH, Lim CH et al. 2009; Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. J Biomed Mat Res Part B 91B: 163–171.
43. Zhang SG. 2003; Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 21: 1171–1178.